Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982 Apr;45(4):491-9.
doi: 10.1038/bjc.1982.84.

Distribution of T-lymphocyte subsets in Hodgkin's disease characterized by monoclonal antibodies

Free PMC article

Distribution of T-lymphocyte subsets in Hodgkin's disease characterized by monoclonal antibodies

M S Dorreen et al. Br J Cancer. 1982 Apr.
Free PMC article

Abstract

Mononuclear-cell suspensions of lymph nodes, spleen and blood from 24 patients with active Hodgkin's disease (HD) were studied for possible imbalance of T and B lymphocytes, and T-lymphocyte subsets, using monospecific anti-T antibodies and other reagents. A profile showing T-cell predominance was demonstrated in lymph nodes and blood, with total T-cells ranging from 50-70% of the cell count. As defined by monoclonal antibodies, 70-85 of the latter comprised the "inducer" subclass, the remainder being "suppressor" cells. There were no essential differences between histologically involved and uninvolved lymph nodes from HD patients, though total T-cell proportions were lower in "normal lymph node" controls. The profiles of spleens electively removed, as part of pre-treatment staging procedures, showed reduced total T-cell numbers, whether these were involved with HD or not. These differences are accounted for principally by fewer T "inducer" cells (24%, in spleen, v. 54% in involved lymph nodes and 47% in "normal" control nodes). Possible explanations for these findings are discussed. Our results demonstrate similar profiles in histologically diseased and normal tissue, rather than any clear imbalance of T-cell proportions which might explain the profound disturbances of T-cell function frequently demonstrated in vivo and in vitro.

PubMed Disclaimer

References

    1. Cancer Res. 1966 Jun;26(6):1063-83 - PubMed
    1. Cancer Res. 1971 Nov;31(11):1860-1 - PubMed
    1. Arch Intern Med. 1973 Mar;131(3):446-54 - PubMed
    1. Science. 1973 Sep 21;181(4105):1133-41 - PubMed
    1. Natl Cancer Inst Monogr. 1973 May;36:107-15 - PubMed

Substances